Topic: Prostate
September is Prostate Cancer Awareness Month. Visit the MedlinePlus prostate cancer topic page to learn more. ... moreDETROIT An incisionless robotic surgical procedure is offering patients a new option to remove certain head and neck cancer tumors without visible scarring, while preserving speech and the ability ... more
In a recent study, researchers demonstrated that conditional small RNA molecules can effectively kill lab-grown human brain, prostate and bone cancer cells in a mutation-specific manner. The treatment ... more
Demand for healthcare services in both the U.S. and abroad is expected to increase in the coming years. Aided by new advances in medical care, people across the globe are living longer. Here in the ... more
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain a ... more
CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive. Since 2003, the CyberKnife Center of Miami and the Cybe ... more
Members of the Prostate Cancer Roundtable, consisting of America's Leading Prostate Cancer Organizations, are asking President Obama to place a blue ribbon on the White House and light the White House ... more
Men with early, probably non-aggressive prostate cancer (determined by lower PSA levels and the presence of low-grade tumor pathology) can safely postpone surgery. ... more
A new survey says they don't know that finasteride is used for chemoprevention. Urologists fear the drug could raise the risk of tumors. ... more
Now that the Centers for Medicare #038; Medicaid Services has caused a ruckus by unexpectedly conducting a so-called National Coverage Analysis for the Provenge prostate cancer vaccine, the agency la ... more
Today s New York Times book review of Invasion of the Prostate Snatchers: No More Unnecessary Biopsies, Radical Treatment or Loss of Sexual Potency caught ACSH #39;s Dr. Gilbert Ross attention. ... more
Drugmakers regularly complain that it is getting more difficult and more expensive to recruit people into clinical trials, hence the rush overseas (background here and here). So how should a drugmaker ... more
Biopsies taken to diagnose prostate cancer commonly cause temporary erectile dysfunction and, in some cases, lingering urinary problems, according to a new study.Source: Reuters Health Related Medline ... more
Family history is an important risk factor for prostate cancer, but a new study suggests that the risk is inflated by diagnostic activity. Medscape Medical News ... more
One of the challenges of prostate cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men. ... more
Hypertension (High Blood Pressure) Prostate Cancer Related Pain Type 2 Diabetes /div ... more
AARP Bulletin: "Retail prices for some of the most widely used brand-name prescription drugs shot up more than 8 percent in 2009, even as inflation plummeted to a record low, according to a new AARP a ... more
A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed ... more
The latest people to object to the recent decision by the Centers for Medicare #038; Medicaid Services to open a National Coverage Analysis of the Provenge prostate cancer vaccine happen to be two US ... more
Men who show signs that their disease has returned after prostate cancer treatment are still more likely to die of other causes, a new study in US veterans shows.Source: Reuters Health Related Medline ... more
Men who have undergone surgery to treat earlier stage prostate cancer may not need to keep up yearly PSA tests to screen for a cancer recurrence, a new study suggests.Source: Reuters Health Related Me ... more
Starting in September, President Obama's Affordable Care Act will go into effect. The act mandates free preventative services such as cholesterol or breast cancer screenings and tetanus shots. But the ... more
A new study from Sweden suggests that the of risk of prostate cancer in men with a known family history of the disease could be inflated because such men are more likely to seek a diagnosis, further ... more
Source: National Institute of Environmental Health Sciences - Related MedlinePlus Page: Pesticides ... more
A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed ... more
A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed ... more
Some treatments might be less costly short term, but more expensive over time, study finds Source: HealthDay Related MedlinePlus Page: Prostate Cancer ... more
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. Published early online in Cancer, a p ... more
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. Published early online in Cancer, a p ... more
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. ... more
Some treatments might be less costly short term, but more expensive over time, study finds ... more
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. Published early online in Cancer, a p ... more
Surgery for localised prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at the Universi ... more
Low testosterone levels to blame for low libido, fatigue and weight gain CHICAGO While most frequently associated with women #8217;s health, age-related hormone changes, often dubbed menopause, can ... more
The brothers of men with prostate cancer are at an increased risk of prostate cancer diagnosis because of increased diagnostic activity and not necessarily because they carry a genetic mutation that i ... more
Booster Shots, the Los Angeles Times health blog, yesterday pointed out that while the current prostate cancer screening technology mdash; the prostate-specific antigen (PSA) test mdash; has lead ... more
Advances in medicine have allowed people in developed countries to live longer, but at a cost: An increased lifespan raises a patient #8217;s likelihood of developing health issues such as angina or i ... more
We've discussed the medical benefits of beer before, most recently as a risk management tool against developing prostate cancer.Unfortunately, it turns out that beer may have other, less helpful side- ... more
Increased diagnostic activity may lead to siblings finding more early stage disease, study suggests Source: HealthDay Related MedlinePlus Pages: Family History, Health Screening, Prostate Cancer ... more
The brothers of men with prostate cancer are at an increased risk of prostate cancer diagnosis because of increased diagnostic activity and not necessarily because they carry a genetic mutation that i ... more
Increased diagnostic activity may lead to siblings finding more early stage disease, study suggests ... more
The Prostate Cancer Foundation (PCF) invites patients, survivors and prostate cancer supporters to attend a breakfast on September 14, 2010 at 8:45 a.m. in the Courtyard of The Washington Hilton. The ... more
Scientists have discovered an accomplice in breast cancer a master control switch with the power to set off a cascade of reactions orchestrated by a cancer-causing gene (or oncogene) named Wnt1. Th ... more
Questions About Prostate Cancer Prognosis of the Lockerbie Bomber Medscape Medical News ... more
Last week we discussed how doctors have been reluctant to prescribe finasteride to men as a prophylactic treatment for prostate cancer. Marketed as Proscar by Merck, finasteride has been shown to redu ... more
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer. The compound, now ... more
Only 27% of men who used Propecia (finasteride) said it was very effective. Finasteride is a 5-alpha reductase inhibitor used to treat prostate enlargement symptoms and baldness. Finasteride has ... more
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer. The compound, now ... more
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prosta ... more
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prosta ... more
Malignant gliomas are the most common subtype of primary brain tumor and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to pros ... more
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices ndash; signallin ... more
Erroneous fear that finasteride spurs more aggressive tumors has left some physicians wary, research shows Source: HealthDay Related MedlinePlus Pages: Drug Safety, Prostate Cancer ... more
The boom in cancer biomarker investments over the past 25 years has not translated into major clinical success. The reasons for biomarker failures include problems with study design and interpretation ... more
Now we are seeing doctors failing to prescribe a prophylactic treatment for prostate cancer. ... more
Erroneous fear that finasteride spurs more aggressive tumors has left some physicians wary, research shows ... more
Researchers have found that men enrolled in an active surveillance program for prostate cancer that eventually needed surgery to remove their prostates fared just as well as men who opted to remove th ... more
Augmenix, Inc. announced that Prof. Michael Eble and Dr. Michael Pinkawa of the Aachen University Hospital, Aachen, Germany, performed a commercial implantation of the company's CE Mark approved Space ... more
A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered. While these results are only preliminary, the study publis ... more
Top of the morning to you. And a sunny one it is. Hope your day is getting off to a good start. As for us, we have the usual laundry list of meetings and deadlines, which calls for a cup of stimulatio ... more
An "electronic nose" could be used as a simple breath test to detect lung, breast, bowel and prostate cancers, Israeli scientists said Wednesday.Source: Reuters Health Related MedlinePlus Pages: Cance ... more
Androgen deprivation therapy (ADT) is reportedly associated with increased risks of diabetes, coronary artery disease, myocardial infarction (MI), sudden cardiac death, and stroke. In the online edit ... more
Bladder cancer invasive into the pelvic side wall or into adjacent organs other than the prostate, vagina, and uterus is classified as clinical stage T4b. Locally advanced tumors of this category are ... more
Bladder cancer invasive into the pelvic side wall or into adjacent organs other than the prostate, vagina, and uterus is classified as clinical stage T4b. Locally advanced tumors of this category are ... more
Developments could reduce biopsies, promote #8216;watchful waiting #8217; for low-grade cancers NEW BRUNSWICK, N.J. Rutgers researchers are developing methods that can accurately assess the severi ... more
Despite the dramatic results of the Prostate Cancer Prevention Trial, which showed a significant reduction in prostate cancer among those taking finasteride, physicians have not increased its use, acc ... more
Researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians ... more
Chemotherapy drugs are powerful anti-cancer agents, but they can also cause adverse side effects such as rashes, nausea, and allergic reactions. Reformulating a popular drug offers pharmaceutical comp ... more
A large clinical trial showed that finasteride can reduce the risk for prostate cancer, yet it is not widely prescribed. Some experts feel that its use as a chemopreventive agent is premature. Meds ... more
Prostate cancer (PrCa) cells form differentiated spheroids or "prostaspheres" in three-dimensional cell culture (3D culture) when embedded in extracellular matrix such as MatrigelTM, rat tail collagen ... more
A new study found that 75% of men with low PSA and low-risk prostate cancer receive aggressive treatment such as radiation or radical prostatectomy. ... more
A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role i ... more
Researchers explain how a facultative enzyme governs tumor growth This release is available in French. Inhibiting prostate cancer without disturbing regular body processes Researchers explain how a f ... more
Common medications might affect prostate cancer diagnoses, researchers saySource: HealthDay Related MedlinePlus Pages: Pain Relievers, Prostate Cancer, Statins ... more
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF. The di ... more
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study. ... more
Oxford BioMedica plc announces that it has received approval from the US Food and Drug Administration (FDA) and Recombinant DNA Advisory Committee (RAC) to initiate a clinical Phase II study in the U ... more
Abdel Baset Al-Megrahi, the only Lockerbie bomber convicted of the bombing of Pan Am Flight 103 that killed 270 people, was freed on compassionate grounds a year ago because he was supposedly on the b ... more
Abdel Baset Al-Megrahi, the only Lockerbie bomber convicted of the bombing of Pan Am Flight 103 that killed 270 people, was freed on compassionate grounds a year ago because he was supposedly on the b ... more
How #8217;s this for a budget battle? With all of the economic pain around the country, the Milwaukee teachers union has chosen an interesting issue over which to draw a line in the sand - they want a ... more
Common medications might affect prostate cancer diagnoses, researchers say ... more
One of the challenges of prostate cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men. Now, new ... more
Pilot study by NewYork-Presbyterian/Columbia urologic surgeons reports on technology #8217;s potential NEW YORK (August 5, 2010) #8212; One of the challenges of prostate cancer surgery is removing th ... more
One of the challenges of prostate cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men. ... more
Researchers at Columbia University have published the dramatic effects of a natural 33-ingredient compound against prostate cancer cell lines. The impressive results are found in the most recent publi ... more
Despite the dramatic results of the Prostate Cancer Prevention Trial (PCPT), which showed a significant reduction in prostate cancer among those taking finasteride, physicians have not increased its u ... more
A trial with human subjects shows that the device can detect tumors at early stages and locate the edges of a tumor during surgery UC Davis researchers have developed a laser probe for the early detec ... more
In a sharply worded letter to the Centers for Medicare #038; Medicaid Services, the American Society of Clinical Oncology takes the federal agency to task for conducting a coverage review of the Prov ... more
The National Institute for Health and Clinical Excellence has terminated a review of Amgen s osteoporosis drug Prolia for National Health Service prostate cancer patients on a lack of evidence. The ... more
The National Institute for Health and Clinical Excellence has terminated a review of Amgen s osteoporosis drug Prolia for National Health Service prostate cancer patients on a lack of evidence. The ... more
A large study in Japan into possible genetic causes for prostate cancer has uncovered five new gene variants that have never been seen in previous studies in Caucasians, researchers said on Monday.Sou ... more
A genome-wide study on Japanese subjects has identified 5 new genetic variations linked to prostate cancer and revealed differences and similarities between Europeans and Asians in susceptibility to t ... more
Studies have revealed a potential marker for prostate cancer. A new analysis technique to create a profile of the lipids, or fats, found in prostate tissue and revealed a molecular compound that appea ... more
UroToday.com - In the online edition of the International Journal of Cancer, Dr. Ali Murad and colleagues report that non-steroidal anti-inflammatory drugs (NSAIDs) do not decrease the risk of PSA-det ... more
UroToday.com - Endocrine treatment (ET), which interrupts testosterone regulation of the prostate tumor, is the cornerstone treatment for men with locally advanced or metastatic prostate cancer. A num ... more
UroToday.com - Radical cystectomy is the most effective treatment for patients with organ confined muscle invasive or recurrent high grade non muscle invasive bladder cancer. Although minimally invasi ... more
UroToday.com - External beam radiotherapy (EBRT) is a well-established curative treatment for localized prostate cancer. Acute and late toxicity rates after EBRT can be considerable and have been the ... more
UroToday.com - In our recently published paper in Supportive Care in Cancer we report on significant racial disparities in traumatic stress for men with prostate cancer. In particular, African Americ ... more
UroToday.com - The role of antimicrobial prophylaxis for prevention of post transrectal ultrasound guided prostate biopsy (TGB) infections is well established. Although a variety of antimicrobial re ... more
UroToday.com - Dr. Michael Zelefsky and colleagues from the Department of Radiation Oncology at Memorial Sloan-Kettering Cancer Center report in Urology on the feasibility of using CT during prostate ... more
UroToday.com - In Urologia Internationalis, a group headed by Dr. Arnulf Stenzl report on the use of the prostate cancer gene 3 (PCA3) test in their clinical practice in Tübingen, Germany. PCA3 de ... more
UroToday.com - In the July, 2010 edition of The Prostate, David Schilling and colleagues from the Department of Urology, under the direction of Arnulf Stenzel, in Tuebingen, Germany report on a novel ... more
UroToday.com - This study is extremely practical and adds some information concerning the role of elevated PSA and the diagnosis of prostate cancer. Non-malignant conditions such as benign prostate hy ... more
UroToday.com - Pathologic variables following radical prostatectomy (RP) for prostate cancer (CaP) that might suggest benefit from adjuvant radiotherapy include a positive surgical margin (PSM), semin ... more
UroToday.com - In the online edition of the British Journal of Urology International, a group of investigators report on the selection of initial management for low-risk prostate cancer (CaP) in a con ... more
UroToday.com - One mechanism of castration-resistant prostate cancer growth and progression is by activation of the androgen receptor via the non-receptor tyrosine kinase, Src kinase. Src is activate ... more
UroToday.com - In the past several years, germline mutations in small sections of DNA, referred to as single nucleotide polymorphisms (SNPs) have been shown to correlate with the risk of developing pr ... more
UroToday.com - This study was conducted to examine whether simultaneous transrectal prostate needle biopsy (TPNB) due to an increase in PSA levels is safe and effective in patients who are scheduled f ... more
UroToday.com - In the online edition of the International Journal of Cancer, Dr. Ali Murad and colleagues report that non-steroidal anti-inflammatory drugs (NSAIDs) do not decrease the risk of PSA-det ... more
UroToday.com - Endocrine treatment (ET), which interrupts testosterone regulation of the prostate tumor, is the cornerstone treatment for men with locally advanced or metastatic prostate cancer. A num ... more
UroToday.com - External beam radiotherapy (EBRT) is a well-established curative treatment for localized prostate cancer. Acute and late toxicity rates after EBRT can be considerable and have been the ... more
UroToday.com - Dr. Michael Zelefsky and colleagues from the Department of Radiation Oncology at Memorial Sloan-Kettering Cancer Center report in Urology on the feasibility of using CT during prostate ... more
UroToday.com - In Urologia Internationalis, a group headed by Dr. Arnulf Stenzl report on the use of the prostate cancer gene 3 (PCA3) test in their clinical practice in Tübingen, Germany. PCA3 de ... more
UroToday.com - Pathologic variables following radical prostatectomy (RP) for prostate cancer (CaP) that might suggest benefit from adjuvant radiotherapy include a positive surgical margin (PSM), semin ... more
UroToday.com - In the online edition of the British Journal of Urology International, a group of investigators report on the selection of initial management for low-risk prostate cancer (CaP) in a con ... more
UroToday.com - In the past several years, germline mutations in small sections of DNA, referred to as single nucleotide polymorphisms (SNPs) have been shown to correlate with the risk of developing pr ... more
August 2010 #8212; Stress urinary incontinence is one of the most feared complications of radical prostatectomy. The weighted mean continence rate immediately after catheter removal following robot-a ... more
A genome-wide study on Japanese subjects has identified 5 new genetic variations associated with prostate cancer and revealed differences and similarities between Europeans and Asians in susceptibilit ... more
Emphasizing low rate of prostate testing had unintended effect, study findsSource: HealthDay Related MedlinePlus Pages: Health Screening, Prostate Cancer ... more
Altered Herpes Virus May Fight Head and Neck Cancer: Study FDA Approves 1st Embryonic Stem Cell Trial Using Patients Study Pinpoints Cells Linked to Prostate ... more
UroToday.com - Over the last few years, epidemiological and population studies have suggested that African Americans have a higher incidence and a higher mortality rate of prostate cancer than other e ... more
Emphasizing low rate of prostate testing had unintended effect, study finds ... more
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientis ... more
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and m ... more
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light- ... more
Scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more e ... more
But FDA-approved Provenge remains very expensive, experts note Source: HealthDay Related MedlinePlus Pages: Immunization, Prostate Cancer ... more
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next s ... more
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, sugg ... more
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next s ... more
After three years of hype and hope over the Provenge prostate cancer vaccine, a study published in The New England Journal of Medicine may finally offer Dendreon some long-sought validation for its co ... more
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, sugg ... more
The pivotal trial that showed a survival advantage and led to approval is now published, but the lack of a measurable antitumor effect is "surprising." Medscape Medical News ... more
But FDA-approved Provenge remains very expensive, experts note ... more
ACSH #39;s Dr. Elizabeth Whelan has been pointing out for years that many men receive overly aggressive treatment for low-risk prostate cancer. Her assertion has been backed up again, this time in a s ... more
More than 75% of men diagnosed with low-risk prostate cancer undergo aggressive treatment -- either complete removal of the prostate or radiation therapy, according to a new study. ... more
In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therapies target the rece ... more
Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens. ... more
Given the intense interest in the Provenge prostate cancer vaccine, Wall Street is closely tracking the launch of the controversial Dendreon product, which was recently launched at a price tag of $93, ... more
File this under #8217;should have known better. #8217; Last year, GlaxoSmithKline wanted to promote its Avodart drug for shrinking enlarged prostates, so it paid for a supplement in the May 2009 edit ... more
The latest issue of the New Companies #038; Technologies Report (NCTR) has been published on innovative companies and technologies in health and medicine. * If you are not a subscriber to the Intelli ... more
The company is a medical devices company that has developed a novel therapeutic technology for the treatment of prostate cancer. The company s apparatus uses non-invasive MRI imaging to identify pro ... more
People who send off their saliva to genetic testing companies to find out their risk for prostate cancer or diabetes are likely to get different results, depending on the company they choose, governme ... more
Many would do just as well with watchful waiting, researchers say Source: HealthDay Related MedlinePlus Page: Prostate Cancer ... more
New research from the US suggests that most American men diagnosed with prostate cancer receive aggressive treatment, even if their prostate-specific antigen (PSA) level is below the current recommen ... more
Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profi ... more
A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai's Samuel Oschin Comprehensive Cance ... more
A group of researchers from Wake Forest University Baptist Medical Center is developing a way to treat cancer by using lasers to light up tiny nanoparticles and destroy tumors with the ensuing heat. ... more
Researchers at the USC Norris Comprehensive Cancer Center have received a $12 million National Cancer Institute (NCI) grant to lead a multi-institution international project aimed at identifying new b ... more
DALLAS July 22, 2010 Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens. Researchers ... more
Researchers have found that blocking one of the enzymatic steps that allow a prostate tumor to produce androgens could be the key in halting a tumor's growth. ... more
by Crystal Phend Deferring curative treatment for low-risk prostate cancer may be a good option for many men ages 70 and younger, a population-based observational study affirmed. In t ... more
Siemens Healthcare Diagnostics has developed a fully automated Sex Hormone Binding Globulin (SHBG) immunoassay for testing plasma or serum samples on the ADVIA Centaur® platform. A free Prostate Spec ... more
The Keck School of Medicine of the University of Southern California (USC) has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dol ... more
Surgical robots were once considered a fantastical invention of sci-fi authors. But the future, as they say, is now. The Harvard Business Review listed surgical robots as one of its 10 Innovations Th ... more
Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important c ... more
Every few weeks, something unexpected happens to keep the Provenge prostate cancer vaccine in the news in a big way. Last month, the Centers for Medicare #038; Medicaid Services unexpectedly decided ... more
#8220;The innovative factor contributed by our work is its relevance to population and measurement of relative survival, which enables us to discover survival related to cancer in a more precise way ... more
>Doctor Describes Natural Extract That Stops Cancer Cells It s been talked about in whispers in the halls of Washington , D.C. and in some of the more elite research labs in the country: ... more
Prostate cancer is the second leading cause of cancer-related deaths in men, and diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including ... more
Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therap ... more
Men with prostate cancer lose significantly less bone mineral content (BMC) as they age than men who are free of the disease. The findings are important because loss of BMC can play a key role in the ... more
A team of investigators has identified a series of proteins that might make it easier for doctors to better diagnose the more metastatic forms of prostate cancer. ... more
Light has been cast on the interaction between broccoli consumption and reduced prostate cancer risk. Researchers writing in BioMed Central's open access journal Molecular Cancer have found that sulfo ... more
Light has been cast on the interaction between broccoli consumption and reduced prostate cancer risk. Researchers writing in BioMed Central #8217;s open access journal Molecular Cancer have found that ... more
Light has been cast on the interaction between broccoli consumption and reduced prostate cancer risk. Researchers have found that sulforaphane, a chemical found in broccoli, interacts with cells lacki ... more
Recent genetic association studies have uncovered a number of DNA variants associated with prostate cancer. However, some of these risk variants lie outside of genes, posing a challenge to researchers ... more
Researchers uncover a mechanism that determines prostate cancer aggressiveness, providing new targets for diagnosis and treatment LA JOLLA, Calif., July 12, 2010 Some types of prostate tumors are m ... more
Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duk ... more
Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, according to Duke Un ... more
utube.com/watch?v=B9bDZ5-zPtY feature=channel">TEDtalksDirector May 17, 2010 - William Li presents a new way to think about cancer treatment: angiogenesis, targeting the blood vessels that feed a ... more
Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, according to researc ... more
The Centers for Medicare #038; Medicaid Services is unexpectedly conducting a national coverage analysis of the Provenge prostate cancer vaccine (back story), but what do private insurers think? A ne ... more
The unending quest to ensure that the Provenge prostate cancer vaccine is approved and readily available to patients has seen a group of activists - some are investors and some are patients - take on ... more
Chapel Hill, NC In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therap ... more
A recent study provides demonstrates that expression of one of a group of genes found only in humans and non-human primates can promote androgen receptor activity in concert with other proteins called ... more
... more
Dendreon Corporation (Nasdaq: DNDN) announced that the Centers for Medicare and Medicaid Services (CMS) initiated a National Coverage Analysis (NCA) of PROVENGE® (sipuleucel-T), an autologous cellula ... more
With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American ... more
The decision by the Centers for Medicare #038; Medicaid Services to review Dendreon #8217;s Provenge prostate cancer vaccine caused investors to dump the stock in after-hours trading Wednesday night. ... more
Medicare officials are considering whether covering a drug used to treat prostate cancer is worth the cost, The Wall Street Journal reports. The announcement that the Centers for Medicare and Med ... more
A large study shows that screening men for prostate cancer decreased mortality rates by about half, researchers report. ... more
Progress toward understanding the role of sex hormones in the growth of prostate cancer -- the most common cancer in US men -- has been hindered by the lack of a suitable laboratory research model. No ... more
Last night, the latest chapter in the Provenge saga was unexpectedly written - the news that the Centers for Medicare #038; Medicaid Services was reviewing coverage for the Provenge prostate cancer v ... more
New data from a Swedish study show that population screening with PSA in men between 50 and 69 years of age reduces prostate cancer mortality by almost half. Medscape Medical News ... more
Swedish report adds to controversy over the usefulness of the blood screen Source: HealthDay Related MedlinePlus Pages: Laboratory Tests, Prostate Cancer ... more
Akash Patnaik, MD, PhD, a physician-scientist in the Hematology/Oncology Divison at Beth Israel Deaconess Medical Center (BIDMC) and Instructor of Medicine at Harvard Medical School has received a You ... more
A new study from Sweden revealed that screening men between 50 and 65 years old with the PSA test for prostate cancer reduced deaths by nearly a half over 14 years and concluded that prostate cancer ... more
Researchers at the Uniformed Services University of the Health Sciences (USU) Center for Prostate Disease Research (CPDR), in collaboration with investigators at the Armed Forces Institute of Patholog ... more
A new study from Sweden revealed that screening men between 50 and 65 years old with the PSA test for prostate cancer reduced deaths by nearly a half over 14 years and concluded that prostate cancer ... more
Progress toward understanding the role of sex hormones in the growth of prostate cancerthe most common cancer in U.S. menhas been hindered by the lack of a suitable laboratory research model. Now ... more
Nothing like an after-hours plunge in a stock. Dendreon shares fell as much as 23 percent this evening after the Centers for Medicare #038; Medicaid Services announced it is reviewing the prostate ca ... more
Swedish report adds to controversy over the usefulness of the blood screen ... more
Statins lowered the risk for biochemical recurrence in some men who used the drugs at surgery or radiotherapy for prostate cancer. Is it time to study this prospectively? Medscape Medical News ... more
Large-scale cancer genome characterization projects on glioblastoma, lung, colon, pancreas, and breast cancers have been undertaken. One is now available online on prostate cancer. Medscape Medical ... more
COLUMBUS, Ohio Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have discovered how a sub ... more
But connection needs to be confirmed by future study, researcher says Source: HealthDay Related MedlinePlus Pages: Prostate Cancer, Statins ... more
Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duk ... more
Cholesterol-lowering statin drugs appear to lower the risk for prostate cancer recurrences. ... more
Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to a new study. Resea ... more
Type 2 adult-onset diabetes causes insulin-like hormones to circulate through the body. A new study finds this has a surprisingly positive effect on reducing the rate of prostate cancer in men, but is ... more